231 related articles for article (PubMed ID: 8094991)
1. Structure-activity relationships of analogs of the endogenous brain peptides Tyr-MIF-1 and Tyr-W-MIF-1.
Erchegyi J; Zadina JE; Qiu XD; Kersh DC; Ge LJ; Brown MM; Kastin AJ
Pept Res; 1993; 6(1):31-8. PubMed ID: 8094991
[TBL] [Abstract][Full Text] [Related]
2. Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1).
Erchegyi J; Kastin AJ; Zadina JE
Peptides; 1992; 13(4):623-31. PubMed ID: 1359507
[TBL] [Abstract][Full Text] [Related]
3. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
Zadina JE; Kastin AJ; Ge LJ; Hackler L
Life Sci; 1994; 55(24):PL461-6. PubMed ID: 7990646
[TBL] [Abstract][Full Text] [Related]
4. Tyr-MIF-1 and hemorphin can act as opiate agonists as well as antagonists in the guinea pig ileum.
Zadina JE; Kastin AJ; Kersh D; Wyatt A
Life Sci; 1992; 51(11):869-85. PubMed ID: 1355851
[TBL] [Abstract][Full Text] [Related]
5. Endogenous peptide Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) is transported from the brain to the blood by peptide transport system-1.
Banks WA; Kastin AJ; Ehrensing CA
J Neurosci Res; 1993 Aug; 35(6):690-5. PubMed ID: 8105102
[TBL] [Abstract][Full Text] [Related]
6. Structural specificity of MIF-1 and Tyr-MIF-1 in augmenting GABA-stimulated benzodiazepine receptor binding.
Miller LG; Kastin AJ; Roy RB; Gaver A; Fischman AJ; Horvath A
Res Commun Chem Pathol Pharmacol; 1988 Nov; 62(2):365-8. PubMed ID: 2908009
[TBL] [Abstract][Full Text] [Related]
7. Binding of Tyr-W-MIF-1 (Tyr-Pro-Trp-Gly-NH2) and related peptides to mu 1 and mu 2 opiate receptors.
Zadina JE; Paul D; Gergen KA; Ge LJ; Hackler L; Kastin AJ
Neurosci Lett; 1996 Aug; 215(1):65-9. PubMed ID: 8880755
[TBL] [Abstract][Full Text] [Related]
8. A Tyr-W-MIF-1 analog containing D-Pro2 discriminates among antinociception in mice mediated by different classes of mu-opioid receptors.
Nakayama D; Watanabe C; Watanabe H; Mizoguchi H; Sakurada T; Sakurada S
Eur J Pharmacol; 2007 Jun; 563(1-3):109-16. PubMed ID: 17343845
[TBL] [Abstract][Full Text] [Related]
9. A Tyr-W-MIF-1 analog containing D-Pro2 acts as a selective mu2-opioid receptor antagonist in the mouse.
Watanabe H; Nakayama D; Ito K; Watanabe C; Mizoguchi H; Fujimura T; Murayama K; Kawamura S; Sato T; Sakurada C; Sakurada T; Sakurada S
J Pharmacol Exp Ther; 2005 Mar; 312(3):1075-81. PubMed ID: 15561796
[TBL] [Abstract][Full Text] [Related]
10. Tyr-W-MIF-1 attenuates down-regulation of opiate receptors in SH-SY5Y human neuroblastoma cells.
Harrison LM; Kastin AJ; Zadina JE
J Pharmacol Exp Ther; 1998 Feb; 284(2):611-7. PubMed ID: 9454805
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal Tyr-W-MIF-1 produces potent, naloxone-reversible analgesia modulated by alpha 2-adrenoceptors.
Gergen KA; Zadina JE; Kastin AJ; Paul D
Eur J Pharmacol; 1996 Mar; 298(3):235-9. PubMed ID: 8846821
[TBL] [Abstract][Full Text] [Related]
12. Analgesic effects of Tyr-W-MIF-1: a mixed mu2-opioid receptor agonist/mu1-opioid receptor antagonist.
Gergen KA; Zadina JE; Paul D
Eur J Pharmacol; 1996 Nov; 316(1):33-8. PubMed ID: 8982647
[TBL] [Abstract][Full Text] [Related]
13. Effects of newly synthesized analogs of MIF-1 containing unnatural amino acids on electrically evoked smooth muscle contractions.
Pajpanova T; Bocheva A; Golovinsky E
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):591-4. PubMed ID: 10669902
[TBL] [Abstract][Full Text] [Related]
14. Tyr-W-MIF-1-induced conditioned place preference.
Nores WL; Olson RD; Olson GA; Vaccarino AL; Bell RL; Zadina JE; Kastin AJ
Peptides; 1999; 20(4):479-84. PubMed ID: 10458518
[TBL] [Abstract][Full Text] [Related]
15. Study on the antinociceptive action of Tyr-K-MIF-1, a peptide from the MIF family.
Zamfirova R; Bocheva A; Dobrinova Y; Todorov S
Auton Autacoid Pharmacol; 2007 Apr; 27(2):93-8. PubMed ID: 17391278
[TBL] [Abstract][Full Text] [Related]
16. Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat.
Bhargava HN; Kim HS
J Pharmacol Exp Ther; 1982 Feb; 220(2):394-8. PubMed ID: 6120229
[TBL] [Abstract][Full Text] [Related]
17. Hemorphins, cytochrophins, and human beta-casomorphins bind to antiopiate (TYR-MIE-1) as well as opiate binding sites in rat brain.
Zadina JE; Kastin AJ; Ge LJ; Brantl V
Life Sci; 1990; 47(8):PL25-30. PubMed ID: 1976197
[TBL] [Abstract][Full Text] [Related]
18. Isolation of Tyr-W-MIF-1 from bovine hypothalami.
Hackler L; Kastin AJ; Erchegyi J; Zadina JE
Neuropeptides; 1993 Mar; 24(3):159-64. PubMed ID: 8097302
[TBL] [Abstract][Full Text] [Related]
19. Structure-activity relationships of enkephalins in the stimulated guinea pig ileum.
Day AR; Luján M; Dewey WL; Harris LS; Radding JA; Freer RJ
Res Commun Chem Pathol Pharmacol; 1976 Aug; 14(4):597-603. PubMed ID: 959662
[TBL] [Abstract][Full Text] [Related]
20. Opioid binding profile of morphiceptin, Tyr-MIF-1 and dynorphin-related peptides in rat brain membranes.
Sartania N; Benyhe S; Magyar A; Rónai AZ; Medzihradszky K; Borsodi A
Neuropeptides; 1996 Jun; 30(3):225-30. PubMed ID: 8819146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
